{"DataElement":{"publicId":"7801425","version":"1","preferredName":"Prostate Gland Additional Uninvolved Anatomy Finding Type","preferredDefinition":"The type of added, extra or further molecular evidence, or absence of evidence, of prostate disease.","longName":"7801424v1.0:7801012v1.0","context":"MCL","contextVersion":"1","DataElementConcept":{"publicId":"7801424","version":"1","preferredName":"Prostate Gland Additional Uninvolved Anatomy Finding","preferredDefinition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen._Added; extra; further._An indication that an anatomy site or entity does not show signs of a disease process._Clinical, laboratory or molecular evidence, or absence of evidence of disease.","longName":"2320019v1.0:7802262v1.0","context":"MCL","contextVersion":"1","ObjectClass":{"publicId":"2320019","version":"1","preferredName":"Prostate","preferredDefinition":"A gland in the male reproductive system just below the bladder. It surrounds part of the urethra, the canal that empties the bladder. It produces a fluid that forms part of semen. (NCI-GLOSS)","longName":"C12410","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Gland","conceptCode":"C12410","definition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC6EF0D8-50A9-6865-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7802262","version":"1","preferredName":"Additional Uninvolved Anatomy Finding","preferredDefinition":"Added; extra; further.:An indication that an anatomy site or entity does not show signs of a disease process.:Clinical, laboratory or molecular evidence, or absence of evidence of disease.","longName":"C25406:C183164:C3367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Additional","conceptCode":"C25406","definition":"Added; extra; further.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Uninvolved Anatomy","conceptCode":"C183164","definition":"An indication that an anatomy site or entity does not show signs of a disease process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFE7E530-4A81-25B5-E053-4EBD850A416B","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-11-03","modifiedBy":"ONEDATA","dateModified":"2021-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CF81BB8C-92C9-249C-E053-4EBD850AD522","latestVersionIndicator":"Yes","beginDate":"2021-10-29","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-29","modifiedBy":"COLBERTM","dateModified":"2022-02-28","changeDescription":"2/28/22 mr Released per SME.   10/29/21 mr Created for MCL PCA prostate per DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7801012","version":"1","preferredName":"Prostate Gland Finding Type","preferredDefinition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen._Clinical, laboratory or molecular evidence, or absence of evidence of disease._Something distinguishable as an identifiable class based on common qualities.","longName":"7801012v1.0","context":"MCL","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559666","version":"1","preferredName":"Other","longName":"2559666","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B61F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"LISU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF59A258-D5D0-1ACA-E053-4EBD850AB1E4","beginDate":"2021-10-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-27","modifiedBy":"ONEDATA","dateModified":"2021-10-27","deletedIndicator":"No"},{"value":"Not reported","valueDescription":"Not Reported","ValueMeaning":{"publicId":"2572231","version":"1","preferredName":"Not Reported","longName":"2572231","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E734-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-11-16","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF59A258-D5DB-1ACA-E053-4EBD850AB1E4","beginDate":"2021-10-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-27","modifiedBy":"ONEDATA","dateModified":"2021-10-27","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF59A258-D5E6-1ACA-E053-4EBD850AB1E4","beginDate":"2021-10-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-27","modifiedBy":"ONEDATA","dateModified":"2021-10-27","deletedIndicator":"No"},{"value":"Prostatic Intraductal adenocarcinoma","valueDescription":"Intraductal Prostate Carcinoma","ValueMeaning":{"publicId":"7801013","version":"1","preferredName":"Intraductal Prostate Carcinoma","longName":"7801013","preferredDefinition":"An intra-acinar and/or intraductal neoplastic epithelial proliferation in the prostate gland that has some features of high-grade prostatic intraepithelial neoplasia but exhibits much greater architectural and/or cytological atypia, typically associated with high-grade, high-stage prostate carcinoma. (WHO 2016)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Intraductal Carcinoma","conceptCode":"C161022","definition":"An intra-acinar and/or intraductal neoplastic epithelial proliferation in the prostate gland that has some features of high-grade prostatic intraepithelial neoplasia but exhibits much greater architectural and/or cytological atypia, typically associated with high-grade, high-stage prostate carcinoma. (WHO 2016)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF59A258-D5F1-1ACA-E053-4EBD850AB1E4","latestVersionIndicator":"Yes","beginDate":"2021-10-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-27","modifiedBy":"ONEDATA","dateModified":"2021-10-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF59A258-D60A-1ACA-E053-4EBD850AB1E4","beginDate":"2021-10-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-27","modifiedBy":"ONEDATA","dateModified":"2021-10-27","deletedIndicator":"No"},{"value":"Benign prostatic hyperplasia (BPH)","valueDescription":"Benign Prostatic Hyperplasia","ValueMeaning":{"publicId":"2577137","version":"1","preferredName":"Benign Prostatic Hyperplasia","longName":"2577137","preferredDefinition":"A non-cancerous nodular enlargement of the prostate gland.  It is characterized by the presence of epithelial cell nodules, and stromal nodules containing fibrous and smooth muscle elements.  It is the most common urologic disorder in men, causing blockage of urine flow.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benign Prostatic Hyperplasia","conceptCode":"C2897","definition":"A non-cancerous nodular enlargement of the prostate gland.  It is characterized by the presence of epithelial cell nodules, and stromal nodules containing fibrous and smooth muscle elements.  It is the most common urologic disorder in men, causing blockage of urine flow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA5E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF59A258-D61E-1ACA-E053-4EBD850AB1E4","beginDate":"2021-10-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-27","modifiedBy":"ONEDATA","dateModified":"2021-10-27","deletedIndicator":"No"},{"value":"Inflammation","valueDescription":"Inflammation","ValueMeaning":{"publicId":"2581231","version":"1","preferredName":"Inflammation","longName":"2581231","preferredDefinition":"A localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inflammation","conceptCode":"C3137","definition":"A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A5C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-17","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF59A258-D629-1ACA-E053-4EBD850AB1E4","beginDate":"2021-10-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-27","modifiedBy":"ONEDATA","dateModified":"2021-10-27","deletedIndicator":"No"},{"value":"High-grade prostatic intraepithelial neoplasia (PIN)","valueDescription":"High Grade Prostatic Intraepithelial Neoplasia","ValueMeaning":{"publicId":"2581149","version":"1","preferredName":"High Grade Prostatic Intraepithelial Neoplasia","longName":"2581149","preferredDefinition":"Prostatic intraepithelial neoplasia characterized by the presence of morphologically malignant cells lining the acini and ducts. The malignant cells are enlarged, contain prominent nucleoli, and have increased nuclear/cytoloplasmic ratio. The malignant cells may grow within the ducts and acini in four architectural patterns: flat, tufting, micropapillary, and cribriform. The presence of high grade prostatic intraepithelial neoplasia in needle biopsy is a risk factor for the subsequent detection of carcinoma on repeat biopsy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade Prostatic Intraepithelial Neoplasia","conceptCode":"C5541","definition":"Prostatic intraepithelial neoplasia characterized by the presence of morphologically malignant cells lining the acini and ducts.  The malignant cells are enlarged, contain prominent nucleoli, and have increased nuclear/cytoplasmic ratio.  The malignant cells may grow within the ducts and acini in four architectural patterns: flat, tufting, micropapillary, and cribriform.  The presence of high grade prostatic intraepithelial neoplasia in needle biopsy is a risk factor for the subsequent detection of carcinoma on repeat biopsy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A0A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF59A258-D634-1ACA-E053-4EBD850AB1E4","beginDate":"2021-10-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-27","modifiedBy":"ONEDATA","dateModified":"2021-10-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2179409","version":"1","preferredName":"Findings","preferredDefinition":"Clinical manifesations that can be either objective when observed by a physician, or subjective when perceived by the patient","longName":"FINDINGS","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"CFCBA97B-C908-5D7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7805103","version":"1","preferredName":"Prostate Gland Finding Type","preferredDefinition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.:Clinical, laboratory or molecular evidence, or absence of evidence of disease.:Something distinguishable as an identifiable class based on common qualities.","longName":"C12410:C3367:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Gland","conceptCode":"C12410","definition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFFACDCA-2E53-1A48-E053-4EBD850ACAFC","latestVersionIndicator":"Yes","beginDate":"2021-11-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-11-04","modifiedBy":"ONEDATA","dateModified":"2021-11-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CF59A258-D5B9-1ACA-E053-4EBD850AB1E4","latestVersionIndicator":"Yes","beginDate":"2021-10-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-27","modifiedBy":"COLBERTM","dateModified":"2022-02-28","changeDescription":"2/28/22 mr Released per SME.   11/4/21 mr Updated qualifiers.   10/27/21 mr Created for MCL PCA prostate per DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506113","version":"1","longName":"Prostate","context":"MCL","ClassificationSchemeItems":[{"publicId":"7781145","version":"1","longName":"Prostate PCA Pilot","context":"MCL"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001794","version":"1","longName":"Prostate PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"additonal_findings_uninvolved_prostate","type":"MCL Alt Name","context":"MCL"}],"ReferenceDocuments":[{"name":"Additional findings, uninvolv","type":"Preferred Question Text","description":"Additional findings, uninvolved prostate","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"prostate_v0_13aug2020.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CF81F25D-12E5-3360-E053-4EBD850A7898","latestVersionIndicator":"Yes","beginDate":"2021-10-29","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-10-29","modifiedBy":"COLBERTM","dateModified":"2022-02-25","changeDescription":"2/25/22 mr Released per SME.   11/4/21 mr Updated VD.   10/29/21 mr Created for MCL PCA prostate. Added alt name, ref doc, CSI per DCT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}